Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2

Cyril Planchais; Ignacio Fernández; Timothée Bruel; Guilherme Dias de Melo; Matthieu Prot; Maxime Beretta; Pablo Guardado-Calvo; Jérémy Dufloo; Luis M. Molinos-Albert; Marija Backovic; Jeanne Chiaravalli; Emilie Giraud; Benjamin Vesin; Laurine Conquet; Ludivine Grzelak; Delphine Planas; Isabelle Staropoli; Florence Guivel-Benhassine; Mikaël Boullé; Minerva Cervantes-Gonzalez; - French COVID Cohort Study Group; - CORSER Study Group; Marie-Noëlle Ungeheuer; Pierre Charneau; Sylvie van der Werf; Fabrice Agou; Jordan D. Dimitrov; Etienne Simon-Lorière; Hervé Bourhy; Xavier Montagutelli; Félix A. Rey; Olivier Schwartz; Hugo Mouquet.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-486719

Documentos relacionados

  1. Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
  2. A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
  3. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
  4. Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants.
  5. Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins.
  6. Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease.
  7. High-resolution map of the Fc functions mediated by COVID-19-neutralizing antibodies.
  8. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
  9. SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals.
  10. PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection.